DK0587264T3 - Vandige farmaceutiske formuleringer indeholdende natriumcromoglycat - Google Patents

Vandige farmaceutiske formuleringer indeholdende natriumcromoglycat

Info

Publication number: DK0587264T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical formulations; formulations containing; containing sodium; aqueous pharmaceutical; sodium cromoglycate
Prior art date: 1992-07-07

Application number

DK93301442.5T

Other languages

English (en)

Inventor

Lewis James Baskeyfield

Steven Paul Probert

Grahm Frederick Jay

Original Assignee

Fisons Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-07

Filing date

1993-02-25

Publication date

1995-03-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10718322&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0587264(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-02-25 Application filed by Fisons Plc filed Critical Fisons Plc

1995-03-06 Application granted granted Critical

1995-03-06 Publication of DK0587264T3 publication Critical patent/DK0587264T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK93301442.5T 1992-07-07 1993-02-25 Vandige farmaceutiske formuleringer indeholdende natriumcromoglycat DK0587264T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB929214390A GB9214390D0 (en)	1992-07-07	1992-07-07	Formulations

Publications (1)

Publication Number	Publication Date
DK0587264T3 true DK0587264T3 (da)	1995-03-06

Family

ID=10718322

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93301442.5T DK0587264T3 (da)	1992-07-07	1993-02-25	Vandige farmaceutiske formuleringer indeholdende natriumcromoglycat

Country Status (12)

Country	Link
US (1)	US5475023A (da)
EP (1)	EP0587264B1 (da)
JP (1)	JP2916340B2 (da)
BE (1)	BE1005196A0 (da)
CA (1)	CA2090911C (da)
DE (1)	DE69300017T2 (da)
DK (1)	DK0587264T3 (da)
FR (1)	FR2686513B1 (da)
GB (1)	GB9214390D0 (da)
IE (1)	IE64551B1 (da)
IT (1)	ITMI20011389A1 (da)
NO (1)	NO302398B1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5532270A (en) *	1995-04-03	1996-07-02	Ascent Pharmaceuticals, Inc.	Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions
US5552436A (en) *	1995-04-03	1996-09-03	Ascent Pharmaceuticals, Inc.	Process for treating hemangioma
US5576346A (en) *	1995-04-03	1996-11-19	Ascent Pharmaceuticals, Inc.	Process for treating uremic pruritus
WO2003013548A1 (en) *	2001-08-09	2003-02-20	Sekisui Chemical Co., Ltd.	Medical composition for external use for dermatosis
US6596284B1 (en)	2002-04-30	2003-07-22	Thomas E. Fleming	Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers
ES2457442T3 (es)	2009-05-08	2014-04-25	Pari Pharma Gmbh	Formulaciones farmacéuticas concentradas estabilizadoras de los mastocitos
CA2938996A1 (en)	2014-02-10	2015-08-13	Patara Pharma, LLC	Methods for the treatment of lung diseases with mast cell stabilizers
PT3104853T (pt)	2014-02-10	2020-01-14	Respivant Sciences Gmbh	Tratamento com estabilizadores de mastócitos para distúrbios sistémicos
US10265296B2 (en)	2015-08-07	2019-04-23	Respivant Sciences Gmbh	Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
EP3331522A1 (en)	2015-08-07	2018-06-13	Patara Pharma LLC	Methods for the treatment of mast cell related disorders with mast cell stabilizers
JP2019528320A (ja)	2016-08-31	2019-10-10	レシュピファントサイエンシスゲゼルシャフトミットベシュレンクターハフトゥングＲｅｓｐｉｖａｎｔＳｃｉｅｎｃｅｓＧｍｂｈ	特発性肺線維症による慢性咳の治療のためのクロモリン組成物
EP3522983A4 (en)	2016-10-07	2020-06-03	Respivant Sciences GmbH	CROMOLYNE-BASED COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3975536A (en) *	1971-05-12	1976-08-17	Fisons Limited	Composition
GB1473318A (en) *	1973-05-25	1977-05-11	Fisons Ltd	Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
US4053628A (en) *	1971-05-12	1977-10-11	Fisons Limited	Composition
GB1593097A (en) *	1978-05-26	1981-07-15	Fisons Ltd	Pharmaceutical compositions containing a bischromone
JPH0218393A (ja) *	1988-07-06	1990-01-22	Nitto Chem Ind Co Ltd	人工水晶の製造方法
WO1990013284A1 (en) *	1989-04-29	1990-11-15	Fisons Plc	Pharmaceutical composition containing sodium cromoglycate
EP0413583A3 (en) *	1989-08-18	1991-07-17	Dey Laboratories; Inc.	Clear, stable cromolyn formulation

1992
- 1992-07-07 GB GB929214390A patent/GB9214390D0/en active Pending
1993
- 1993-02-25 EP EP93301442A patent/EP0587264B1/en not_active Revoked
- 1993-02-25 DK DK93301442.5T patent/DK0587264T3/da active
- 1993-02-25 DE DE69300017T patent/DE69300017T2/de not_active Revoked
- 1993-03-01 IE IE930148A patent/IE64551B1/en not_active IP Right Cessation
- 1993-03-03 CA CA002090911A patent/CA2090911C/en not_active Expired - Lifetime
- 1993-03-03 NO NO930781A patent/NO302398B1/no not_active IP Right Cessation
- 1993-03-08 JP JP5046213A patent/JP2916340B2/ja not_active Expired - Lifetime
- 1993-03-08 BE BE9300223A patent/BE1005196A0/fr not_active IP Right Cessation
- 1993-03-08 FR FR9302655A patent/FR2686513B1/fr not_active Expired - Fee Related
1994
- 1994-07-28 US US08/281,792 patent/US5475023A/en not_active Expired - Lifetime
2001
- 2001-06-29 IT IT2001MI001389A patent/ITMI20011389A1/it unknown

Also Published As

Publication number	Publication date
JPH0672869A (ja)	1994-03-15
CA2090911A1 (en)	1994-01-08
DE69300017T2 (de)	1995-03-30
EP0587264B1 (en)	1994-10-26
ITMI20011389A1 (it)	2002-12-29
NO930781L (no)	1994-01-10
DE69300017D1 (de)	1994-12-01
US5475023A (en)	1995-12-12
FR2686513B1 (fr)	1995-05-24
NO930781D0 (no)	1993-03-03
IE930148A1 (en)	1994-01-12
NO302398B1 (no)	1998-03-02
IE64551B1 (en)	1995-08-23
GB9214390D0 (en)	1992-08-19
FR2686513A1 (fr)	1993-07-30
EP0587264A1 (en)	1994-03-16
JP2916340B2 (ja)	1999-07-05
BE1005196A0 (fr)	1993-05-18
CA2090911C (en)	2004-05-18
ITMI20011389A0 (it)	2001-06-29

Publication	Publication Date	Title
PT589843E (pt)	2002-04-29	Composicoes farmaceuticas contendo ciclosporinas
DK0585252T3 (da)	2001-11-12	Farmaceutiske formuleringer
FI921060A7 (fi)	1992-09-15	Farmaseuttiset aerosoliformulaatiot
ITBO910024A0 (it)	1991-01-30	Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale
DK0673240T3 (da)	1999-10-11	Stabiliserede medicinske aerosolopløsningsformuleringer
DK481989D0 (da)	1989-09-29	Farmaceutiske formuleringer
DK0515312T3 (da)	1996-11-18	Farmaceutisk præparat
EE03426B1 (et)	2001-06-15	Risperidooni vesilahuselised ravimvormid
FI951098L (fi)	1995-03-09	Farmaseuttinen pakkaus
FI964682A7 (fi)	1997-01-20	Glukagonia sisältävä farmaseuttinen valmiste
NO943044D0 (no)	1994-08-17	Formuleringer som inneholder hyaluronsyre
FI930882A0 (fi)	1993-02-26	Farmaceutiska foereningar
FI944123L (fi)	1994-09-08	Farmaseuttiset inhalaatiokoostumukset
NO923127D0 (no)	1992-08-11	Farmasoeytisk kombinasjonsformulering
ITMI921123A0 (it)	1992-05-11	Formulazioni farmaceutiche orali contenenti antocianosidi
DK0587264T3 (da)	1995-03-06	Vandige farmaceutiske formuleringer indeholdende natriumcromoglycat
IT1198247B (it)	1988-12-21	Formulazioni farmaceutiche acquose di ubichinone
DE4294862T1 (de)	1994-06-09	Pharmazeutische Komposition
MX9200146A (es)	1992-07-01	Composiciones farmaceuticas deglutibles
NO934145L (no)	1994-05-19	Farmasöytiske forbindelser
FI931251A7 (fi)	1993-09-25	Farmaseuttisia yhdisteitä
DK0511991T3 (da)	1996-11-11	Farmaceutisk formulering
FI934387A7 (fi)	1994-04-08	3-substituoituja 2-oksi-indoli-1-karboksiamidia käsittäviä farmaseuttisia koostumuksia
FI923869L (fi)	1993-03-06	Farmaceutiska aemnen
FI923369L (fi)	1993-01-28	Vattenhaltiga kompositioner